home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Long Live Transplants!

 
  November, 1 2007 1:40
your information resource in human molecular genetics
 
     
A new strategy to improve transplant survival in diabetic patients is presented online in Nature Medicine.

In some individuals, Type 1 diabetes can be treated by transplanting pancreatic islets, but long-term survival of the transplants has been difficult to achieve. Islet grafts are rejected by the immune system, and efforts to increase their survival are usually aimed at dampening immune T-cell function.

Because B cells -- another type of immune cell -- may also play a role in graft rejection, Ali Naji and colleagues tested the effect of depleting B cells in monkeys transplanted with islet allografts. The authors found that rituximab, a B-cell depleting antibody approved for the treatment of Non-Hodgkin's Lymphoma and rheumatoid arthritis, in combination with T-cell depleting therapy could extend survival of the grafts in some animals.

Long-term graft survival also normalized blood sugar levels, suggesting that B-cell depletion should be studied further for its potential benefit to therapies aimed at improving survival of islet transplants used to treat Type 1 diabetes.

Author contact:

Ali Naji (University of Pennsylvania School of Medicine, Philadelphia, PA, USA)
E-mail: ali.naji@uphs.upenn.edu

Abstract available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.